News Quantified

AHKSY – asahi kaisei crp unsp/adr (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy [Yahoo! Finance]

Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases [Yahoo! Finance]

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

Asahi Kasei (AHKSY) was upgraded by Zacks Research from "hold" to "strong-buy".

Top News Gainers

3/23 ZOLL Executing a Plan to Build 10,000 Ventilators/Month in Response to COVID-19 Pandemic 6.8%

11/25 Asahi Kasei makes $1.3 billion offer for stake in Denmark's Veloxis [Reuters] 6.2%

10/9 Developers of lithium-ion batteries win Nobel Prize in Chemistry [Toronto Globe and Mail (Ontario, Canada)] 5.4%

1/28 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.9%

1/14 Scripps La Jolla First in U.S. to Use ZOLL’s FDA-approved Supersaturated Oxygen Therapy on Patients Suffering From Widowmaker Heart Attacks 2.8%

6/11 ZOLL Signs Definitive Agreement to Purchase Cardiac Science 2.6%

3/30 FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients 1.9%

1/1 Nobel for a Battery Breakthrough Was Decades in the Making [Yahoo! Finance News] 1.4%

6/18 Zoll Medical Corporation Acquires TherOx, Inc. 0.7%

6/10 Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients 0.7%

Top News Decliners

3/31 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -5.6%

3/28 How a College Final Became a Lesson in Survival [The New York Times] -2.8%

10/9 The Science Behind The Lithium-Ion Battery Research That Won 2019’s Nobel Prize In Chemistry [Forbes] -2.4%

10/9 If You’re Reading This On Your Phone, Thank Today’s New Nobelists [Forbes] -2.2%

8/7 ASAHI KASEI COR/ADR (OTCMKTS: AHKSY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -0.8%

8/27 ZOLL Medical Completes Acquisition of Cardiac Science -0.5%

11/11 AI company AiCure takes in $24.5 mln Series C [Reuters] -0.2%

7/22 ZOLL Acquires Mobilize RRS LLC. -0.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day